Breaking News Instant updates and real-time market news.

CNAT

Conatus

$1.96

-0.04 (-2.00%)

16:15
10/03/16
10/03
16:15
10/03/16
16:15

Conatus announces acceptance of Emricasan abstracts for AASLD annual meeting

Conatus Pharmaceuticals announced that abstracts for four posters - two addressing clinical results and two addressing preclinical results with the company's pan-caspase inhibitor, emricasan - have been accepted for presentation at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases, AASLD, in Boston November 11-15.

CNAT Conatus
$1.96

-0.04 (-2.00%)

05/09/16
BMUR
05/09/16
NO CHANGE
Target $7
BMUR
Buy
Conatus price target lowered to $7 from $13 at Brean Capital
Brean Capital lowered its price target on Conatus to $7 from $13 as the firm believes data from its Phase ll liver cirrhosis study has yielded inconclusive results. Brean Capital lowered its price target based on cutting the probability of success for emricasan in liver cirrhosis to 20% from 30%. Brean Capital maintained its Buy rating on Conatus shares, as they believe the company remains on the forefront of developing liver disease treatments.
07/01/16
ROTH
07/01/16
INITIATION
Target $4
ROTH
Buy
Conatus coverage resumed with a Buy at Roth Capital
Roth Capital analyst Sa'ar Yaniv resumed coverage of Conatus with a Buy rating and $4 price target.
08/29/16
HCWC
08/29/16
NO CHANGE
Target $15
HCWC
Buy
Conatus drug further validated by collaboration, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce keeps a Buy rating on Conatus Pharmaceuticals following the company's collaboration agreement with Exalenz Biosciences. The analyst remains positive on Conatus's prospects in non-alcoholic steatohepatitis cirrhosis. The collaboration brings the use of Exalenz's BreathID Methacetin Breath Test to monitor patients in the upcoming Phase 2b trial evaluating the safety and efficacy of emricasan in 160 patients with liver cirrhosis associated with NASH and severe portal hypertension, Arce tells investors in a research note. Using a "simple and non-invasive test provides not only further scientific validation of emricasan for the treatment of NASH cirrhosis, but it also serves as the first non-invasive test that can assist clinicians to conveniently and cost-effectively monitor the effect of the drug at the point of care," the analyst writes. He has a Buy rating on Conatus with a $15 price target.
09/20/16
STFL
09/20/16
NO CHANGE
Target $6
STFL
Buy
Stifel says Conatus emricasan an interesting asset amid increased focus on NASH
Following Allergan's (AGN) acquisition of small-cap NASH play Tobira (TBRA), Stifel analyst Stephen Willey notes there are some "interesting" similarities between Conatus (CNAT) and the latter. However, the analyst points out that the clearest distinctions between the two are Conatus' emphasis on some of the downstream consequences of NASH fibrosis and the amount of meaningful clinical data generated to date. Willey still thinks Conatus' emricasan is an interesting asset, but urges investors seeking Tobira-like premiums to exercise a level of caution. He reiterates a Buy rating and $6 price target on Conatus' shares. In afternoon trading, shares of Conatus have gained about 20% to $2.10.

TODAY'S FREE FLY STORIES

SXL

Sunoco Logistics

$24.29

-0.065 (-0.27%)

, ETP

Energy Transfer Partners

$36.37

-0.05 (-0.14%)

13:43
04/26/17
04/26
13:43
04/26/17
13:43
Hot Stocks
Energy Transfer Partners holders approve Sunoco Logistics merger »

Sunoco Logistics Partners…

SXL

Sunoco Logistics

$24.29

-0.065 (-0.27%)

ETP

Energy Transfer Partners

$36.37

-0.05 (-0.14%)

ETE

Energy Transfer Equity

$19.33

0.78 (4.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 23

    May

XOM

Exxon Mobil

$81.98

0.25 (0.31%)

13:43
04/26/17
04/26
13:43
04/26/17
13:43
Hot Stocks
Exxon Mobil raises dividend to 77c from 75c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

ATVI

Activision Blizzard

$51.36

0.48 (0.94%)

13:39
04/26/17
04/26
13:39
04/26/17
13:39
Hot Stocks
Activision Blizzard unveils next 'Call of Duty,' says launching November 3 »

Activision Blizzard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 09

    May

NTRA

Natera

$8.62

0.26 (3.11%)

13:33
04/26/17
04/26
13:33
04/26/17
13:33
Hot Stocks
Natera, Cancer Research UK publish results from 100 patients in TRACERx study »

Natera and Cancer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

HCLP

Hi-Crush Partners

$15.05

-0.05 (-0.33%)

13:33
04/26/17
04/26
13:33
04/26/17
13:33
Options
Hi Crush Partners calls are active ahead of earnings »

Hi Crush Partners calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

NFLX

Netflix

$152.16

8.33 (5.79%)

, FB

Facebook

$146.49

1.02 (0.70%)

13:32
04/26/17
04/26
13:32
04/26/17
13:32
Hot Stocks
FCC chairman Pai proposes to roll back net neutrality rules »

As previewed in recent…

NFLX

Netflix

$152.16

8.33 (5.79%)

FB

Facebook

$146.49

1.02 (0.70%)

AMZN

Amazon.com

$907.62

0.21 (0.02%)

GOOG

Alphabet

$872.30

9.54 (1.11%)

GOOGL

Alphabet Class A

$888.84

9.91 (1.13%)

CMCSA

Comcast

$38.49

0.48 (1.26%)

CMCSK

Comcast

T

AT&T

$40.11

0.17 (0.43%)

VZ

Verizon

$47.29

0.5937 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 02

    May

  • 03

    May

  • 08

    May

  • 09

    May

  • 16

    May

  • 16

    May

  • 16

    May

  • 17

    May

  • 22

    May

  • 23

    May

  • 05

    Jun

MPLX

MPLX

$36.39

-0.26 (-0.71%)

13:31
04/26/17
04/26
13:31
04/26/17
13:31
Hot Stocks
MPLX raises quarterly distribution 4% to 54c per unit »

MPLX LP announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

CREE

Cree

$24.82

0.07 (0.28%)

, IFNNY

Infineon

$20.70

0.12 (0.58%)

13:29
04/26/17
04/26
13:29
04/26/17
13:29
Recommendations
Cree, Infineon analyst commentary  »

Roth Capital says Cree…

CREE

Cree

$24.82

0.07 (0.28%)

IFNNY

Infineon

$20.70

0.12 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 09

    May

IART

Integra LifeSciences

$43.74

0.86 (2.01%)

13:27
04/26/17
04/26
13:27
04/26/17
13:27
Recommendations
Integra LifeSciences analyst commentary  »

Integra LifeSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 06

    Jun

AA

Alcoa

$36.37

-0.12 (-0.33%)

, KALU

Kaiser Aluminum

$83.84

-0.05 (-0.06%)

13:26
04/26/17
04/26
13:26
04/26/17
13:26
Periodicals
Commerce Secretary to announce plan to investigate aluminum imports, CNBC says »

Commerce Secretary Wilbur…

AA

Alcoa

$36.37

-0.12 (-0.33%)

KALU

Kaiser Aluminum

$83.84

-0.05 (-0.06%)

CENX

Century Aluminum

$13.62

0.99 (7.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZIOP

ZIOPHARM

$7.09

0.25 (3.66%)

13:26
04/26/17
04/26
13:26
04/26/17
13:26
Options
Ziopharm call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 01

    May

  • 02

    Jun

  • 06

    Jun

13:20
04/26/17
04/26
13:20
04/26/17
13:20
General news
Treasury Action: yields jerked higher »

Treasury Action: yields…

$NSD

NASDAQ Market Internals

13:17
04/26/17
04/26
13:17
04/26/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
04/26/17
04/26
13:16
04/26/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
04/26/17
04/26
13:15
04/26/17
13:15
General news
5-Yr Note Auction Coupon Rate data reported »

5-Yr Note Auction Coupon…

13:15
04/26/17
04/26
13:15
04/26/17
13:15
General news
Treasury's $34 B 5-year sale was poor, as feared »

Treasury's $34 B…

13:14
04/26/17
04/26
13:14
04/26/17
13:14
General news
5-Yr Note Auction Total Amount data reported »

5-Yr Note Auction Total…

13:14
04/26/17
04/26
13:14
04/26/17
13:14
General news
Export Prices data reported. »

April Export Prices at % …

13:14
04/26/17
04/26
13:14
04/26/17
13:14
General news
Import Prices data reported. »

April Import Prices at % …

EEM

MSCI Emerging Markets Index

$40.04

-0.16 (-0.40%)

13:11
04/26/17
04/26
13:11
04/26/17
13:11
Options
Notable put spreads in the iShares Emerging Markets ETF »

Notable put spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$227.78

1.15 (0.51%)

, BAC

Bank of America

$24.08

0.095 (0.40%)

13:08
04/26/17
04/26
13:08
04/26/17
13:08
Periodicals
Fed looks to restructure big bank supervision panel, WSJ says »

The Fed is restructuring…

GS

Goldman Sachs

$227.78

1.15 (0.51%)

BAC

Bank of America

$24.08

0.095 (0.40%)

C

Citi

$60.43

0.2199 (0.37%)

WFC

Wells Fargo

$54.90

0.335 (0.61%)

JPM

JPMorgan

$88.61

0.345 (0.39%)

MS

Morgan Stanley

$44.65

0.38 (0.86%)

USB

U.S. Bancorp

$52.36

0.225 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 09

    May

  • 11

    May

  • 19

    May

  • 22

    May

  • 31

    May

  • 06

    Jun

  • 13

    Jul

  • 14

    Jul

  • 18

    Jul

  • 19

    Jul

  • 25

    Jul

  • 12

    Oct

  • 12

    Oct

  • 17

    Oct

  • 18

    Oct

  • 15

    Jan

  • 17

    Jan

  • 13

    Apr

  • 13

    Jul

  • 12

    Oct

X

U.S. Steel

$23.27

-7.84 (-25.20%)

13:06
04/26/17
04/26
13:06
04/26/17
13:06
Downgrade
U.S. Steel rating change  »

U.S. Steel downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

CCCR

China Commercial Credit

$1.82

0.4101 (29.09%)

13:06
04/26/17
04/26
13:06
04/26/17
13:06
Syndicate
Breaking Syndicate news story on China Commercial Credit »

China Commercial Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STX

Seagate

$50.51

1.09 (2.21%)

13:04
04/26/17
04/26
13:04
04/26/17
13:04
Recommendations
Seagate analyst commentary  »

Barclays recommends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    Jun

ROX

Castle Brands

$1.70

0.0993 (6.21%)

13:01
04/26/17
04/26
13:01
04/26/17
13:01
Hot Stocks
Breaking Hot Stocks news story on Castle Brands »

Castle Brands up 13%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.